https://scholars.lib.ntu.edu.tw/handle/123456789/586537
標題: | Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19 | 作者: | WANG-DA LIU CHIEN-CHING HUNG JANN-TAY WANG MING-JUI TSAI Kuo, Po-Hsien TAI-LING CHAO SZU-MIN HSIEH WANG-HUEI SHENG YEE-CHUN CHEN SUI-YUAN CHANG SHAN-CHWEN CHANG |
關鍵字: | Antiretroviral therapy; Coronavirus; Enzyme-linked immunosorbent assay (ELISA); Plaque reduction assay; Severe acute respiratory syndrome | 公開日期: | 21-四月-2021 | 來源出版物: | Journal of the Formosan Medical Association = Taiwan yi zhi | 摘要: | We presented the clinical course and immune responses of a well-controlled HIV-positive patient with COVID-19. The clinical presentation and antibody production to SARS-CoV-2 were similar to other COVID-19 patients without HIV infection. Neutralizing antibody reached a plateau from 26th to 47th day onset but decreased on 157th day after symptoms. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/586537 | ISSN: | 0929-6646 | DOI: | 10.1016/j.jfma.2021.04.010 | SDG/關鍵字: | abacavir; dolutegravir; lamivudine; neutralizing antibody; immunoglobulin G; neutralizing antibody; virus antibody; adult; antibody production; antiretroviral therapy; Article; case report; clinical article; controlled study; coronavirus disease 2019; disease course; enzyme linked immunosorbent assay; human; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; male; virus load; virus neutralization; complication; enzyme linked immunosorbent assay; Human immunodeficiency virus infection; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; Enzyme-Linked Immunosorbent Assay; HIV Infections; Humans; Immunoglobulin G; SARS-CoV-2 |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。